SciNeuro Pharmaceuticals represents the latest in a string of Arch investments directed at the nervous system, a notoriously challenging area of drug development.
A high-stakes meeting with wide-ranging public health implications again didn’t result in a vote, as members struggled to ...
FDA commissioners lambasted the CBER head’s plans to use a probe into COVID vaccine safety to upend longstanding regulatory ...
October meeting with the FDA confirm the agency doesn't see the data collected so far as enough to support an approval filing ...
Høeg, a COVID-19 vaccine critic who’s been serving as a special assistant to the commissioner, will be the fifth person this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback